Astec LifeSciences Limited (NSE:ASTEC)
India · Delayed Price · Currency is INR 718.10
-42.90 (-5.64%)
Sep 10, 2026, 3:30 PM IST
Astec LifeSciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 15,950 | 12,046 | 13,243 | 20,932 | 27,154 | 34,391 | |
Market Cap Growth | -17.39% | -9.04% | -36.73% | -22.91% | -21.04% | 74.99% |
Enterprise Value | 20,342 | 15,622 | 18,229 | 25,222 | 29,616 | 36,253 |
Last Close Price | 715.80 | 540.60 | 670.36 | 1059.72 | 1373.40 | 1739.29 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | 106.22 | 38.27 |
Forward PE | - | 91.24 | 58.44 | 65.84 | 31.83 | 37.10 |
PS Ratio | 3.62 | 2.69 | 3.47 | 4.56 | 4.32 | 5.08 |
PB Ratio | 4.08 | 3.08 | 5.64 | 5.67 | 6.47 | 8.67 |
P/TBV Ratio | 4.36 | 3.29 | 6.27 | 5.98 | 6.73 | 8.93 |
P/OCF Ratio | - | - | - | 204.79 | 36.37 | 145.70 |
PEG Ratio | - | 1.50 | 1.50 | 1.22 | 5.31 | 1.78 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 4.62 | 3.49 | 4.78 | 5.50 | 4.71 | 5.36 |
EV/EBITDA Ratio | - | - | - | - | 39.00 | 23.60 |
EV/EBIT Ratio | - | - | - | - | 68.15 | 30.13 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.15 | 1.15 | 2.36 | 1.34 | 0.81 | 0.70 |
Debt / EBITDA Ratio | 72.88 | - | - | - | 4.47 | 1.81 |
Net Debt / Equity Ratio | 1.12 | 1.12 | 2.36 | 1.34 | 0.81 | 0.70 |
Net Debt / EBITDA Ratio | 76.16 | -83.11 | -8.27 | -80.19 | 4.49 | 1.82 |
Net Debt / FCF Ratio | - | -5.09 | -18.33 | -3.94 | -8.00 | -3.47 |
Asset Turnover | - | 0.49 | 0.41 | 0.47 | 0.67 | 0.86 |
Inventory Turnover | - | 2.07 | 1.72 | 1.32 | 1.69 | 2.68 |
Quick Ratio | - | 0.52 | 0.41 | 0.43 | 0.30 | 0.57 |
Current Ratio | - | 0.89 | 0.93 | 1.00 | 0.95 | 1.05 |
Return on Equity (ROE) | - | -25.84% | -44.57% | -11.88% | 6.27% | 25.46% |
Return on Assets (ROA) | - | -3.38% | -7.40% | -2.66% | 2.90% | 9.55% |
Return on Invested Capital (ROIC) | -4.66% | -6.10% | -13.31% | -5.13% | 4.43% | 15.24% |
Return on Capital Employed (ROCE) | - | -11.20% | -21.30% | -7.20% | 9.60% | 29.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -4.18% | -6.72% | -10.18% | -2.24% | 0.94% | 2.61% |
FCF Yield | -5.41% | -7.16% | -2.28% | -5.99% | -1.57% | -2.34% |
Dividend Yield | - | - | - | 0.14% | 0.11% | 0.09% |
Payout Ratio | - | - | - | - | 11.50% | 3.27% |
Buyback Yield / Dilution | -12.59% | -9.18% | -0.01% | -0.02% | -0.04% | -0.05% |
Total Shareholder Return | -12.59% | -9.18% | -0.01% | 0.13% | 0.07% | 0.04% |